Immunome is a biotech company focused on cancer immunotherapies fueled by the human immune system. Its immunotherapy discovery engine leverages “the most highly educated” immune systems from patients who have already learned how to fight off their disease. The proprietary technology platform enables the simultaneous discovery of antigens and the patient-derived, native antibodies that target those antigens.